E Fund Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

E Fund Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223,808	Closed	-$198K	–	358
2022 Q4	$198K	Buy	223,808 +22,818	+11%	+$30.3K	0.02%	305
2022 Q3	$316K	Buy	200,990 +4,717	+2%	+$10.7K	0.03%	228
2022 Q2	$395K	Buy	196,273 +73,225	+60%	+$127K	0.04%	190
2022 Q1	$287K	Buy	123,048 +95,216	+342%	+$297K	0.01%	210
2021 Q4	$129K	Buy	27,832 +6,068	+28%	+$37.7K	﹤0.01%	281
2021 Q3	$166K	Buy	+21,764	New	+$185K	0.01%	241
2021 Q1	$112K	Buy	+13,528	New	+$143K	0.01%	237

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

E Fund Management's SRNE Position: Q1 2023 in Review

E Fund Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 223,808 shares — an estimated $198K sold.

E Fund Management first reported a position in SRNE in Q1 2021 and held it in 7 quarters. The position peaked at $395K in Q2 2022. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

E Fund Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
E Fund Management sold 223,808 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $198K.
E Fund Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 7 quarters.
E Fund Management's Sorrento Therapeutics, Inc. position peaked at $395K in Q2 2022.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.